Cargando…

BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

Only a small fraction of hereditary breast and/or ovarian cancer (HBOC) cases are caused by germline variants in the high-penetrance breast cancer 1 and 2 genes (BRCA1 and BRCA2). BRCA1-associated ring domain 1 (BARD1), nuclear partner of BRCA1, has been suggested as a potential HBOC risk gene, alth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rofes, Paula, Del Valle, Jesús, Torres-Esquius, Sara, Feliubadaló, Lídia, Stradella, Agostina, Moreno-Cabrera, José Marcos, López-Doriga, Adriana, Munté, Elisabet, De Cid, Rafael, Campos, Olga, Cuesta, Raquel, Teulé, Álex, Grau, Èlia, Sanz, Judit, Capellá, Gabriel, Díez, Orland, Brunet, Joan, Balmaña, Judith, Lázaro, Conxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911518/ https://www.ncbi.nlm.nih.gov/pubmed/33498765 http://dx.doi.org/10.3390/genes12020150

Ejemplares similares

RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant
por: Rofes, Paula, et al.
Publicado: (2021)

Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?
por: Stradella, Agostina, et al.
Publicado: (2019)

Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients
por: del Valle, Jesús, et al.
Publicado: (2020)

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
por: Fernández-Rodríguez, Juana, et al.
Publicado: (2012)

vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines
por: Munté, Elisabet, et al.
Publicado: (2023)

Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer
por: Feliubadaló, Lídia, et al.
Publicado: (2017)

SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015)

Role of POLE and POLD1 in familial cancer
por: Mur, Pilar, et al.
Publicado: (2020)

Evaluation of CNV detection tools for NGS panel data in genetic diagnostics
por: Moreno-Cabrera, José Marcos, et al.
Publicado: (2020)

Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
por: Dueñas, Nuria, et al.
Publicado: (2020)

Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers 2020, 12, 3419
por: Dueñas, Nuria, et al.
Publicado: (2021)

Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment
por: Grabenstetter, Anne, et al.
Publicado: (2020)

Role for a Bard1 SNP in Breast Cancer Susceptibility
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer
por: Chen, Yong-Zi, et al.
Publicado: (2019)

Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?
por: Moles-Fernández, Alejandro, et al.
Publicado: (2018)

Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants
por: Quiles, Francisco, et al.
Publicado: (2013)

Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012)

Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes
por: Moles-Fernández, Alejandro, et al.
Publicado: (2021)

CNVfilteR: an R/Bioconductor package to identify false positives produced by germline NGS CNV detection tools
por: Moreno-Cabrera, José Marcos, et al.
Publicado: (2021)

The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland
por: Stacey, Simon N, et al.
Publicado: (2006)

BARDES coming of age?
Publicado: (2022)

A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape
por: Castellanos, Elisabeth, et al.
Publicado: (2017)

Longer Telomeres Are Associated with Cancer Risk in MMR-Proficient Hereditary Non-Polyposis Colorectal Cancer
por: Seguí, Nuria, et al.
Publicado: (2014)

Patients’ and professionals’ perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic
por: López-Fernández, Adrià, et al.
Publicado: (2021)

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status
por: Prat, Aleix, et al.
Publicado: (2014)

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
por: Klonowska, Katarzyna, et al.
Publicado: (2015)

BARD1 nonsense variant c.1921C>T in a patient with recurrent breast cancer
por: Gass, Jennifer, et al.
Publicado: (2017)

Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
por: Suszynska, Malwina, et al.
Publicado: (2020)

The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers
por: Watters, Andrea K., et al.
Publicado: (2020)

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
por: Weber-Lassalle, Nana, et al.
Publicado: (2019)

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)

Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
por: Alenezi, Wejdan M., et al.
Publicado: (2020)

Dualistic Role of BARD1 in Cancer
por: Cimmino, Flora, et al.
Publicado: (2017)

BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1
por: Witus, Samuel R., et al.
Publicado: (2021)

Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2018)

RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
por: Zhu, Qian, et al.
Publicado: (2021)

BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women
por: Śniadecki, Marcin, et al.
Publicado: (2020)

Acting Shakespeare is outrageous!: playing the bard for beginners
por: Parker, Herb
Publicado: (2017)

A tribute to the Bards of BEACH : Experiment Summary
por: Gibson, V
Publicado: (2014)

Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gfv8s5l1d58c47ebojiv387tqe